Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-09-21Clinical Trial Update: Low-dose Molecular Breast Imaging: Comparison of Breast Cancer Detection Rate at Initial Screening and Two-year Follow-up [NA]
A terminated Mayo Clinic trial evaluating detection rates of low-dose molecular breast imaging at initial screening and at two-year follow-u…
-
CLINICAL_TRIALS trial_result · 2016-09-20Clinical Trial Update: Dovitinib Plus an Aromatase Inhibitor for Metastatic Breast Cancer [Phase 1, Phase 2]
Clinical trial update on dovitinib combined with an aromatase inhibitor for metastatic breast cancer; terminated with results posted in 2016…
-
CLINICAL_TRIALS trial_result · 2016-09-20Clinical Trial Update: Impact of Chemotherapy Followed by Aromatase Inhibitors on Bone Health of Women With ER-positive Early Breast Cancer
This clinical trial update reports on the impact of chemotherapy followed by aromatase inhibitors on bone health in women with estrogen rece…
-
CLINICAL_TRIALS research · 2016-09-20Clinical Trial Update: Selective Lymph Node Dissection Using Fluorescent Dye in Node-positive Breast Cancer [Phase 4]
Phase 4 clinical trial evaluating selective lymph node dissection guided by a fluorescent dye in patients with node-positive breast cancer. …
-
CLINICAL_TRIALS trial_result · 2016-09-20Clinical Trial Update: The Assessment of Molecular Breast Imaging (MBI) in Distinguishing Benign From Malignant Breast Disease [NA]
A completed trial evaluating Molecular Breast Imaging (MBI) for distinguishing benign from malignant breast disease, with results posted in …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-09-19Clinical Trial Update: The Efficacy and Safety of PEG-rhG-CSF in Neutropenia After Chemotherapy [Phase 4]
Phase 4 clinical trial update evaluating the efficacy and safety of PEG-rhG-CSF for neutropenia after chemotherapy in patients with breast c…
-
EMA approval · 2016-09-16New treatment for breast cancer
The EMA announces a new treatment for breast cancer, indicating a regulatory approval or favorable assessment for a breast cancer therapy.
-
CLINICAL_TRIALS research · 2016-09-16Clinical Trial Update: An Innovation During the Surgical Wait; Evaluation of the Opportunity for Intervention
Clinical trial update focused on evaluating opportunities for intervention during the surgical wait for breast cancer patients.
-
CLINICAL_TRIALS trial_result · 2016-09-16Clinical Trial Update: Pilot Study of Sorafenib and Bi-weekly Capecitabine in Patients With Advanced Breast and Gastrointestinal Tumors [Phase 1]
A Phase 1 pilot study evaluating the combination of sorafenib and bi-weekly capecitabine in patients with metastatic breast cancer and gastr…
-
CLINICAL_TRIALS other · 2016-09-16Clinical Trial Update: Doxorubicin Hydrochloride Liposome Injection Combination With Cyclophosphamide vs Pirarubicin Combination With Cyclophosphamide in Patients With Locally Advanced Breast Cancer [Phase 4]
Phase 4 clinical trial update comparing Doxorubicin hydrochloride liposome injection with cyclophosphamide versus pirarubicin with cyclophos…
-
CLINICAL_TRIALS research · 2016-09-16Clinical Trial Update: The Study on the Clinical Utility of Liquid Biopsy in Breast Cancer
This document provides an update on a clinical study evaluating the clinical utility of liquid biopsy in breast cancer. The status of the tr…
-
CLINICAL_TRIALS trial_result · 2016-09-14Clinical Trial Update: Gamma-delta Tocotrienol as Potential Maintenance Treatment in Women With Metastatic Breast Cancer [Phase 1]
Phase 1 trial update on gamma-delta tocotrienol as maintenance treatment in women with metastatic breast cancer, now completed.
-
CLINICAL_TRIALS trial_result · 2016-09-14Clinical Trial Update: Evaluation of Homeopathic Treatment for Hot Flashes in Non Metastatic Breast Cancer [Phase 3]
A Phase 3 trial evaluating homeopathic treatment for hot flashes in non-metastatic breast cancer has completed.
-
CLINICAL_TRIALS withdrawal · 2016-09-14Clinical Trial Update: Trial of Neoadjuvant Trastuzumab Emtansine in Patients With HER2-Equivocal Breast Cancer [Phase 2]
A Phase 2 neoadjuvant trial of trastuzumab emtansine in patients with HER2-equivocal breast cancer has been withdrawn.
-
CLINICAL_TRIALS research · 2016-09-13Clinical Trial Update: Study of Trans-tissular Migration of Macrophages Associated to Human Breast Cancer [NA]
This clinical trial update investigates trans-tissular migration of macrophages associated with breast cancer. The current study status is u…
-
CLINICAL_TRIALS research · 2016-09-12Clinical Trial Update: Cyberknife After Breast Conservative Surgery [NA]
Clinical trial evaluating Cyberknife radiotherapy after breast-conserving surgery for breast cancer; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2016-09-09Clinical Trial Update: Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Non-Metastatic, Post Menopausal Breast Cancer Patients
This ClinicalTrials.gov entry reports a completed study evaluating musculoskeletal symptoms linked to aromatase inhibitors in non-metastatic…
-
CLINICAL_TRIALS trial_result · 2016-09-08Clinical Trial Update: A Study of MM-121 in Combination With Paclitaxel in Patients With Advanced Gynecologic and Breast Cancers [Phase 1]
Phase 1 study evaluating MM-121 in combination with paclitaxel in patients with advanced gynecologic cancers and HER2-non-overexpressing bre…
-
CLINICAL_TRIALS research · 2016-09-08Clinical Trial Update: A Translational Trial on Molecular Markers and Functional Imaging to Predict Response of Preoperative Treatment of Breast Cancer Early [Phase 2]
This Phase 2 translational clinical trial in breast cancer aims to use molecular markers and functional imaging to predict response to preop…
-
CLINICAL_TRIALS trial_result · 2016-09-02Clinical Trial Update: Dose-Dense Docetaxel Before or After Doxorubicin/Cyclophosphamide in Axillary Node-Positive Breast Cancer [Phase 2]
Phase 2 study comparing dose-dense docetaxel given before versus after standard doxorubicin/cyclophosphamide in axillary node-positive breas…
-
CLINICAL_TRIALS trial_result · 2016-09-02Clinical Trial Update: A Trial of Doxorubicin/Cyclophosphamide (AC), Docetaxel (D), and Alternating AC and D for Metastatic Breast Cancer [Phase 3]
A Phase 3 trial investigating alternating cycles of doxorubicin/cyclophosphamide and docetaxel for metastatic breast cancer; the study statu…
-
CLINICAL_TRIALS research · 2016-09-01Clinical Trial Update: A Study of Combinations of D-CIK Immunotherapy And Anti-PD-1 In Refractory Solid Tumors [Phase 1, Phase 2]
A Phase 1/Phase 2 study evaluating combinations of D-CIK immunotherapy with anti-PD-1 therapy in refractory solid tumors, including hepatoce…
-
CLINICAL_TRIALS trial_result · 2016-08-31Clinical Trial Update: Study of ExAblate Focused Ultrasound Ablation of Breast Cancer [Phase 2]
A Phase 2 study evaluating ExAblate focused ultrasound ablation for breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-08-31Clinical Trial Update: Capecitabine and Bevacizumab ± Vinorelbine in Metastatic Breast Cancer [Phase 3]
Phase 3 trial evaluating capecitabine and bevacizumab with or without vinorelbine in metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-08-31Clinical Trial Update: Preoperative Cisplatin in Early Stage Breast Cancer [Phase 2]
This is a Phase 2 clinical trial update evaluating preoperative cisplatin in patients with early-stage breast cancer.